Boswellia and turmeric are two of the most widely used botanical ingredients in joint-support supplements, but they are not the same ingredient and their clinical research is built around different extracts, compounds and dosing strategies. Boswellia is typically standardized around boswellic acids, while turmeric research is often centered on curcuminoids—especially curcumin.
Both have human evidence for joint-related outcomes. They have also been studied together. The important question is not simply which one is “better,” but what each ingredient contributes, how strong the evidence is, and whether combining them has actually produced better outcomes in controlled trials.
Key Takeaways
- Boswellia: a 2020 meta-analysis of seven randomized trials involving 545 participants found significant improvements in pain, stiffness and physical function versus control groups.
- Turmeric/curcumin: a 2021 meta-analysis of 16 randomized controlled trials involving 1,810 adults found significant improvements in knee pain and physical function versus placebo.
- They work through different phytochemical profiles: Boswellia is associated with boswellic acids, while turmeric contains curcuminoids including curcumin.
- They have been studied together: one 2018 randomized trial reported stronger results for a curcumin-plus-boswellic-acid combination than for curcumin alone, but later multi-ingredient trials in 2021 and 2026 did not outperform placebo.
- There is no universal winner: extract quality, standardization, dose, bioavailability and the rest of the formula matter more than simply seeing “Boswellia” or “turmeric” on the front label.
Boswellia vs Turmeric: What Is the Main Difference?
Boswellia serrata is a tree whose gum resin is used to produce standardized botanical extracts. The main compounds commonly discussed in supplements are boswellic acids, including AKBA and other related triterpenes.
Turmeric comes from the rhizome of Curcuma longa. Its best-known compounds are curcuminoids, particularly curcumin. Turmeric root powder, turmeric extracts and purified or enhanced-bioavailability curcumin preparations are not interchangeable in the research.
That difference matters because clinical trials typically evaluate a specific extract, not the generic plant name. A label that identifies the form, standardization and amount gives you much more useful information than one that simply lists “Boswellia” or “turmeric.”
What Does the Research Say About Boswellia for Joint Support?
A 2020 systematic review and meta-analysis evaluated seven randomized controlled trials with 545 participants with osteoarthritis. Compared with control groups, Boswellia and Boswellia extracts were associated with significant improvements in several joint-related outcomes:
- visual-analogue pain scores;
- WOMAC pain;
- WOMAC stiffness;
- WOMAC physical function;
- Lequesne functional index.
The pooled analysis reported a WOMAC pain difference of -14.22, WOMAC stiffness difference of -10.04, and WOMAC function difference of -10.75 compared with controls. The authors described Boswellia as promising while also noting differences between extracts and limitations in the underlying trials. Read the meta-analysis on PubMed.
For a dedicated review of the extract types, boswellic acids, doses and newer trials, read our Boswellia for Joint Support: Benefits, Clinical Evidence & How It Works guide.
What Does the Research Say About Turmeric and Curcumin?
Turmeric has a larger randomized-trial literature, but the preparations vary substantially. Many of the strongest joint studies use concentrated turmeric extracts or curcumin formulations rather than ordinary turmeric root powder.
A 2021 systematic review and meta-analysis included 16 randomized controlled trials and 1,810 adults with knee osteoarthritis. Compared with placebo, turmeric extracts significantly reduced knee pain and improved physical function. The pooled standardized mean difference was -0.82 for pain and -0.75 for physical function.
The review also found that the effects of turmeric extracts were similar to active NSAID comparators in the included trials, while emphasizing that the overall risk of bias was moderate and the studies were heterogeneous. Read the 2021 meta-analysis on PubMed.
An earlier meta-analysis of randomized clinical trials also reported significant improvements in pain and WOMAC outcomes with turmeric or curcumin preparations compared with placebo. Review the earlier meta-analysis on PubMed.
So Which Has Stronger Evidence: Boswellia or Turmeric?
Turmeric and curcumin currently have a larger volume of randomized-trial and meta-analytic research. Boswellia has fewer trials, but several controlled studies and a dedicated meta-analysis report improvements in pain, stiffness and physical function.
That does not make turmeric automatically “better.” The evidence bases answer slightly different questions because the extracts, doses and bioavailability strategies differ. For both botanicals, the specific preparation matters.
A useful way to think about the difference is:
- Boswellia: smaller evidence base, but direct randomized-trial and meta-analytic support for pain, stiffness and function.
- Turmeric/curcumin: larger evidence base with many more randomized trials, but also greater variability between products and delivery systems.
Can Boswellia and Turmeric Be Taken Together?
Boswellia and turmeric are commonly combined in joint-support supplements, and the combination has been tested in human research. However, combining two evidence-backed ingredients does not automatically guarantee a stronger clinical effect.
The strongest way to answer the question is to look at controlled trials that used them together.
A 2018 trial found stronger results for a curcumin + boswellic-acid combination
A randomized, double-blind, placebo-controlled trial enrolled 201 adults aged 40 to 70 with osteoarthritis. Participants received one of three treatments for 12 weeks:
- a curcumin complex;
- a curcumin complex combined with boswellic acid;
- placebo.
The curcumin-plus-boswellic-acid preparation contained 350 mg curcuminoids and 150 mg boswellic acid per 500 mg capsule, taken three times daily. Both active preparations produced favorable effects compared with placebo, but the combination showed significant improvements in both physical performance tests and the WOMAC joint-pain index, with a larger overall effect than curcumin alone.
The authors reported that the products were well tolerated. The manufacturer donated the study capsules but was reported to have no other involvement in the trial. Read the randomized trial on PubMed.
But later multi-ingredient trials produced different results
A 2021 Australian randomized trial studied a broader combination containing Boswellia serrata extract, MSM, curcumin and pine bark in 106 adults with symptomatic hand osteoarthritis. After 12 weeks, there was no significant difference in pain reduction between the supplement and placebo groups. Read the RADIANT trial on PubMed.
More recently, the 2026 ATLAS trial evaluated another multi-ingredient combination containing Boswellia 250 mg, MSM 1,500 mg, curcumin 500 mg, pine bark 100 mg and piperine 5 mg per day in 84 adults with symptomatic knee osteoarthritis. At 12 weeks, pain improved in both groups, but there was essentially no difference between the supplement and placebo groups: the between-group difference was 0.16 mm on a 0–100 mm pain scale, with a 95% confidence interval of -6.81 to 7.12.
The authors concluded that this specific combination was not superior to placebo for knee pain over 12 weeks. Read the 2026 ATLAS trial on PubMed.
What Do the Mixed Combination Results Mean?
They show why supplement research has to be read at the formula level, not just the ingredient-name level.
The 2018 study tested one specific curcumin-plus-boswellic-acid preparation and reported a stronger result than curcumin alone. The later RADIANT and ATLAS trials tested different multi-ingredient formulations, different doses and different patient populations, and did not show superiority over placebo.
These studies do not cancel each other out. They demonstrate that:
- different extracts can behave differently;
- dose and standardization matter;
- bioavailability can change the effective exposure;
- adding more ingredients does not guarantee a better result;
- evidence from one finished formula should not automatically be transferred to another.
Boswellia vs Turmeric: What to Look for on the Label
For Boswellia
- Look for Boswellia serrata identified by species.
- Check the extract amount per full serving.
- Look for standardization to boswellic acids, AKBA or another defined constituent.
- Do not assume equal milligram amounts mean equal potency across different extracts.
For Turmeric
- Distinguish turmeric root powder from concentrated turmeric extract or curcumin.
- Check the amount of curcuminoids when it is stated.
- Look at any bioavailability technology or added piperine.
- Compare the exact form with the form used in clinical research.
What About Bioavailability?
Curcumin has naturally low oral bioavailability, which is why many supplements use phospholipid complexes, proprietary delivery systems or piperine from black pepper to increase absorption.
This is useful context—but higher bioavailability is not automatically better in every situation. The U.S. National Center for Complementary and Integrative Health notes that highly bioavailable curcumin formulations have been associated with reports of liver injury in some people. Review the NCCIH turmeric safety summary.
Boswellia extracts also vary in how they are standardized and delivered. As with turmeric, the research is most useful when the product label makes the exact extract transparent.
Safety Considerations
Boswellia has generally been well tolerated in clinical studies. NCCIH states that Boswellia serrata extract has been used safely in studies at doses up to 1,000 mg per day for as long as six months. See the NCCIH Boswellia safety summary.
Conventional oral turmeric or curcumin is generally considered likely safe in recommended amounts for short-term use, but turmeric can cause gastrointestinal side effects in some people. NCCIH also notes that certain enhanced-bioavailability curcumin products have been associated with liver injury reports.
If you take medication, are pregnant or breastfeeding, have a known medical condition, or are considering a high-dose botanical supplement, review the full formula with a qualified healthcare professional.
Frequently Asked Questions
Is Boswellia better than turmeric for joints?
There is no universal answer. Turmeric has a larger clinical literature, while Boswellia also has randomized-trial and meta-analytic evidence for pain, stiffness and physical function. The exact extract, standardization and dose matter for both.
Do Boswellia and turmeric work in the same way?
No. They contain different families of plant compounds and are studied through different biochemical pathways. Boswellia is associated with boswellic acids, while turmeric research commonly focuses on curcuminoids such as curcumin.
Can Boswellia and turmeric be used in the same joint-support formula?
Yes. They are frequently combined, and human trials have studied them together. Some trials have reported benefits, while other multi-ingredient trials have not outperformed placebo, so the evidence depends on the specific finished formulation.
Is turmeric the same as curcumin?
No. Turmeric is the whole botanical rhizome. Curcumin is one of its major curcuminoids. A turmeric root powder and a concentrated curcumin extract can have very different compositions.
What matters most when comparing Boswellia and turmeric supplements?
Look at the exact extract, amount per serving, standardization, delivery system and whether the formula discloses every active amount. These details make it easier to compare the label with the human research.
The Bottom Line
Both Boswellia and turmeric have meaningful human evidence behind their use in joint-support supplements. Turmeric and curcumin have the larger overall research base, while Boswellia has controlled-trial and meta-analytic evidence for pain, stiffness and function.
They can be combined, but the clinical evidence does not support assuming that every combination will automatically work better than either ingredient alone. The formula, extract, dose and study population all matter.
The best supplement comparison is therefore not “Boswellia or turmeric?” in isolation. It is: What exact form is used, how much is provided, how transparent is the label, and how closely does the formula match the evidence?
Explore the Joint-Support Research
For a deeper review of MSM and glucosamine, read MSM & Glucosamine for Joint Support: Benefits, Clinical Evidence & How They Work. You can also explore our dedicated Boswellia evidence guide.
If you are comparing transparent multi-ingredient joint formulas, visit Movement & Mobility. FlexiCore™ combines Boswellia serrata extract standardized to 65% boswellic acids with turmeric root, MSM, plant-derived GlucosaGreen® glucosamine HCl, hyaluronic acid and complementary ingredients, with active amounts disclosed on the label.
Review the full Supplement Facts and directions for FlexiCore™ here. The ingredient and combination studies discussed in this article are not clinical trials of the finished FlexiCore™ formula.
References
- Yu G, et al. Effectiveness of Boswellia and Boswellia extract for osteoarthritis patients: a systematic review and meta-analysis. BMC Complement Med Ther. 2020. PMID: 32680575. DOI: 10.1186/s12906-020-02985-6.
- Paultre K, et al. Efficacy and Safety of Turmeric Extracts for the Treatment of Knee Osteoarthritis: a Systematic Review and Meta-analysis of Randomised Controlled Trials. Curr Rheumatol Rep. 2021. PMID: 33511486.
- Daily JW, et al. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food. 2016. PMID: 27533649.
- Haroyan A, et al. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study. BMC Complement Altern Med. 2018. PMID: 29316908. DOI: 10.1186/s12906-017-2062-z.
- Liu X, et al. Efficacy and safety of a supplement combination on hand pain among people with symptomatic hand osteoarthritis: the RADIANT study. Osteoarthritis Cartilage. 2021. PMID: 33617972. DOI: 10.1016/j.joca.2021.01.011.
- Yuan S, et al. Effect of an oral complementary medicine combination for symptomatic knee osteoarthritis: A double-blind, randomized, placebo-controlled trial. Osteoarthritis Cartilage. 2026. PMID: 42331134. DOI: 10.1016/j.joca.2026.06.008.
- National Center for Complementary and Integrative Health. Boswellia: Usefulness and Safety.
- National Center for Complementary and Integrative Health. Turmeric: Usefulness and Safety.
This article is for educational purposes and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the U.S. Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure or prevent any disease. Consult a qualified healthcare professional before beginning a new supplement if you take prescription medication, have a medical condition, or are pregnant or breastfeeding.